CLINICAL_TRIALS
trial_result
· 2010-12-06
Clinical Trial Update: IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity [Phase 3]
Summary
Phase 3 trial of IncobotulinumtoxinA (Xeomin) for upper limb spasticity has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz Pharmaceuticals GmbH | Conditions: Upper Limb Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2010-12-06